AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Figure 1: A schematic diagram that illustrates the steps involved in content generation, processing and data analysis for antigen microarrays. Antigen-specific tolerization with epitopes of oral type ...